Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
10.72
+0.17 (1.61%)
Apr 30, 2025, 3:00 PM CST
Heilongjiang ZBD Pharmaceutical Company Description
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China.
It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields.
The company was founded in 1996 and is based in Hulin, China.
Heilongjiang ZBD Pharmaceutical Co., Ltd.
Country | China |
Founded | 1996 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 2,545 |
CEO | Jiujiang Yan |
Contact Details
Address: No. 72 Hongxing Street Hulin, 150060 China | |
Phone | 86 45 8681 1969 |
Website | zbdzy.com |
Stock Details
Ticker Symbol | 603567 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE100002219 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Jiujiang Yan | GM and Director |
Lei Wang | Chief Financial Officer and Accounting Supervisor |
Zhongfang Zhang | Board Secretary |
Tianzhu Li | Deputy General Manager |
Xiuzhen Li | Deputy General Manager |